BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3016377)

  • 1. A case of small cell lung cancer successfully treated with VM26.
    Suga J; Saijo N; Shinkai T; Eguchi K; Sasaki Y; Sakurai M; Sano T; Tamura T; Morinaga S
    Jpn J Clin Oncol; 1986 Jun; 16(2):123-8. PubMed ID: 3016377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Teniposide in the treatment of small-cell lung cancer: the influence of prior chemotherapy.
    Giaccone G; Donadio M; Bonardi G; Testore F; Calciati A
    J Clin Oncol; 1988 Aug; 6(8):1264-70. PubMed ID: 2842464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Teniposide (VM26): an effective treatment for brain metastases of small cell carcinoma of the lung.
    Giaccone G; Donadio M; Bonardi GM; Testore F; Calciati A
    Eur J Cancer Clin Oncol; 1988 Apr; 24(4):629-31. PubMed ID: 2838291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Teniposide (VM26) as second-line treatment for small cell lung cancer.
    Tummarello D; Guidi F; Torresi U; Dazzi C; Cellerino R
    Anticancer Res; 1990; 10(2A):397-9. PubMed ID: 2161198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase II study with teniposide (VM26) in patients with progressed or relapsed small cell lung cancer (SCLC).
    Tummarello D; Guidi F; Di Furia L; Gramazio A; Menichetti E; Cellerino R
    J Chemother; 1989 Feb; 1(1):64-7. PubMed ID: 2542470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors influencing response to second-line treatment with teniposide (VM26) in patients with progressive small cell lung cancer (SCLC).
    Tummarello D; Graziano F; Giordani P; Cellerino R
    Anticancer Res; 1993; 13(4):1055-8. PubMed ID: 8394668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II study of teniposide in small cell carcinoma of the lung.
    Pedersen AG; Bork E; Osterlind K; Dombernowsky P; Hansen HH
    Cancer Treat Rep; 1984 Oct; 68(10):1289-91. PubMed ID: 6098366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical impact of teniposide in the treatment of elderly patients with small-cell lung cancer.
    Cascinu S; Del Ferro E; Ligi M; Graziano F; Catalano G
    Am J Clin Oncol; 1997 Oct; 20(5):477-8. PubMed ID: 9345331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro antitumor activity of teniposide against carcinoma of the lung in human tumor clonogenic assay.
    Matsushima Y; Kanzawa F; Miyazawa N; Sasaki Y; Saijo N
    Anticancer Res; 1986; 6(5):921-4. PubMed ID: 3026235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VM26 (NSC-122819): a clinical study in advanced cancer of the lung and ovary.
    Samson MK; Baker LH; Talley RW; Fraile RJ
    Eur J Cancer (1965); 1978 Dec; 14(12):1395-9. PubMed ID: 216556
    [No Abstract]   [Full Text] [Related]  

  • 11. Phase II study of teniposide (VM26) in cutaneous T-cell lymphomas.
    Sorio R; Tirelli U; Zagonel V; Carbone A; Monfardini S
    Am J Clin Oncol; 1990 Feb; 13(1):14-6. PubMed ID: 2305716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Teniposide (VM-26), an overlooked highly active agent in small-cell lung cancer. Results of a phase II trial in untreated patients.
    Bork E; Hansen M; Dombernowsky P; Hansen SW; Pedersen AG; Hansen HH
    J Clin Oncol; 1986 Apr; 4(4):524-7. PubMed ID: 3007684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity and pharmacokinetics of teniposide in Lewis lung carcinoma-bearing mice.
    Broggini M; Colombo T; D'Incalci M
    Cancer Treat Rep; 1983 Jun; 67(6):555-9. PubMed ID: 6861161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Podophyllotoxins for brain metastases of small cell lung cancer.
    Haaxma-Reiche H; Berendsen HH; Postmus PE
    J Neurooncol; 1988 Nov; 6(3):231-2. PubMed ID: 2852221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Teniposide alone and in combination chemotherapy in small cell lung cancer.
    Giaccone G
    Semin Oncol; 1992 Apr; 19(2 Suppl 6):75-80. PubMed ID: 1329229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA breakage in human lung carcinoma cells and nuclei that are naturally sensitive or resistant to etoposide and teniposide.
    Long BH; Musial ST; Brattain MG
    Cancer Res; 1986 Aug; 46(8):3809-16. PubMed ID: 3015377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two schedules of teniposide with or without cisplatin in advanced non-small-cell lung cancer: a randomized study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group.
    Splinter TA; Sahmoud T; Festen J; van Zandwijk N; Sörenson S; Clerico M; Burghouts J; Dautzenberg B; Kho GS; Kirkpatrick A; Giaccone G
    J Clin Oncol; 1996 Jan; 14(1):127-34. PubMed ID: 8558187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination chemotherapy of the epipodophyllotoxin derivatives, teniposide and etoposide. A pharmacodynamic rationale?
    Allen LM; Tejada F; Okonmah AD; Nordqvist S
    Cancer Chemother Pharmacol; 1982; 7(2-3):151-6. PubMed ID: 7083456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and efficacy of i.v. and i.p. VM26 chemotherapy in mice bearing Krebs II ascitic tumors.
    Canal P; Bugat R; Rokoszak B; Berg D; Soula G; Roche H
    Eur J Cancer Clin Oncol; 1986 Jul; 22(7):765-71. PubMed ID: 3770034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Teniposide in the treatment of small cell lung cancer: a review.
    Hansen HH; Dombernowsky P; Hansen M; Bork E
    Semin Oncol; 1992 Apr; 19(2 Suppl 6):65-8. PubMed ID: 1329227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.